Metraipolis › archive › dc_62cac0241409

Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy — Europe PMC PMID:40860882

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40860882
DOI
10.3389/fphar.2025.1643791
License (as archived)
solo-consultazione
Archived
2026-11-10T17:48:59.638Z
SHA-256 of the archived text
89ad6e7bc3f11a75df8775f15f5b9e40c9cfb808508f6b5108db12dffdc24aba
Stable URL of this page
https://metraipolis.com/documento/dc_62cac0241409

How to cite

Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy — Europe PMC PMID:40860882 — Europe PMC (en), https://europepmc.org/article/MED/40860882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62cac0241409 (Metraipolis archive dc_62cac0241409, sha256 89ad6e7bc3f11a75df8775f15f5b9e40c9cfb808508f6b5108db12dffdc24aba)
BibTeX
@misc{dc62cac0241409,
  title = {Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy — Europe PMC PMID:40860882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40860882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62cac0241409; sha256 89ad6e7bc3f11a75df8775f15f5b9e40c9cfb808508f6b5108db12dffdc24aba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40860882. Agents can read the archived copy with the MCP tool read_document.